ReviewFrontiers in cell and developmental biology2026
Decoding RNF20: an epigenetic modifier and beyond.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
E3 ubiquitin ligases play essential roles in catalyzing the ubiquitination process and are involved in almost all life activities of eukaryotes. RNF20 is a really interesting new gene (RING) finger E3 ubiquitin ligase and is well-known for its role in monoubiquitination of histone H2B. Recent studies have offered new insights into how RNF20 regulates gene expression and developmental programs, and how misregulation of its activities leads to pathologies including developmental disorders and cancers. Here, we provide a current review of the physiological and pathological roles of RNF20 in embryonic development and human diseases, and outline its cellular and molecular modes of action, as well as the upstream control of RNF20 activity, thus providing insights for the molecular basis of RNF20 misregulation associated human diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.